PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALPHA2

Allogene Reports the US FDA's Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma

Allogene Reports the US FDA's Clinical Hold on ALPHA2 Study of ALLO-501A to Treat Large B Cell Lymphoma

October 8, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us